Aspire has successfully submitted the Premarket Tobacco Application (PMTA) to the US FDA

Aspire has successfully submitted Premarket Tobacco Application (PMTA) to be approved by the US Food and Drug Administration (FDA) for its electronic nicotine delivery devices.

The documentation includes a broad and exhaustive investigation with scientific evidence of the quality and safety of our electronic nicotine-delivery systems (ENDS).

Aspire believes in normal and logical regulations to protect the people against harmful tobacco products. We also believe that the ENDS industry should offer high-quality products that comply with health and marketing standards.

Currently, Aspire has submitted the Premarket Tobacco Application (PMTA) to the US FDA for the Aspire Nautilus Prime.

Aspire has successfully submitted the Premarket Tobacco Application (PMTA) to the US FDA was originally posted by E-Sigaret Nieuws